- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances and future of immunotherapy for glioblastoma
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 10, Pages 1245-1264
Publisher
Informa UK Limited
Online
2016-07-13
DOI
10.1080/14712598.2016.1212012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis
- (2017) Bradley A. Gross et al. JOURNAL OF NEUROSURGERY
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
- (2016) Carl Koschmann et al. Science Translational Medicine
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
- (2016) Eileen S. Kim et al. Journal of Immunology Research
- Pathology, molecular mechanisms and markers of gliomas: new insight and new challenges
- (2015) Werner Paulus ACTA NEUROPATHOLOGICA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies
- (2015) Gaetano Finocchiaro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Awakening the immune system with radiation: Optimal dose and fractionation
- (2015) Saumil J. Gandhi et al. CANCER LETTERS
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma
- (2015) Julius W. Kim et al. HUMAN GENE THERAPY
- Overview of current immunotherapeutic strategies for glioma
- (2015) Anda-Alexandra Calinescu et al. Immunotherapy
- The role of checkpoints in the treatment of GBM
- (2015) Jennifer E. Kim et al. JOURNAL OF NEURO-ONCOLOGY
- Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
- (2015) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
- (2015) J. R. Kane et al. NEURO-ONCOLOGY
- Isocitrate dehydrogenase mutations in gliomas
- (2015) Matthew S. Waitkus et al. NEURO-ONCOLOGY
- Outcomes of the ACT III Study
- (2015) Benjamin M. Zussman et al. NEUROSURGERY
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next-generation sequencing: hype and hope for development of personalized radiation therapy?
- (2015) Ingeborg Tinhofer et al. Radiation Oncology
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Recent Technical Advances and Indications for Radiation Therapy in Low-Grade Glioma
- (2015) Michael D. Chan SEMINARS IN RADIATION ONCOLOGY
- Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients
- (2015) Haidar A. Shamran et al. Biomed Research International
- Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
- (2015) Yafei Hou et al. Journal for ImmunoTherapy of Cancer
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- B Cells Are Critical to T-cell—Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma
- (2015) Marianela Candolfi et al. NEOPLASIA
- Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
- (2014) A. Schuessler et al. CANCER RESEARCH
- Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma
- (2014) Rebecca Favaro et al. CANCER RESEARCH
- Blocking Immunosuppressive Checkpoints for Glioma Therapy: The More the Merrier!
- (2014) M. G. Castro et al. CLINICAL CANCER RESEARCH
- Immunotherapy for Brain Cancer: Recent Progress and Future Promise
- (2014) C. M. Jackson et al. CLINICAL CANCER RESEARCH
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Tim-3 on Peripheral CD4+ and CD8+ T Cells Is Involved in the Development of Glioma
- (2014) Song Han et al. DNA AND CELL BIOLOGY
- Adenoviral vector-mediated gene therapy for gliomas: coming of age
- (2014) Maria G Castro et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
- (2014) Martin K. Hunn et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2014) Eiichi Ishikawa et al. JOURNAL OF NEUROSURGERY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
- (2014) Marta Penas-Prado et al. NEURO-ONCOLOGY
- Immunotherapy advances for glioblastoma
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO- IMMUNOTHERAPY
- (2014) F. F. Lang et al. NEURO-ONCOLOGY
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2014) Ray R. Zhang et al. NEUROSURGERY
- Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade
- (2014) Sylwia Libard et al. PLoS One
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- Current Vaccine Trials in Glioblastoma: A Review
- (2014) Linda W. Xu et al. Journal of Immunology Research
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
- (2014) Richard G Everson et al. Journal for ImmunoTherapy of Cancer
- Chromatin Remodeling Defects in Pediatric and Young Adult Glioblastoma: A Tale of a Variant Histone 3 Tail
- (2013) Adam M. Fontebasso et al. BRAIN PATHOLOGY
- Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III
- (2013) D. R. Emlet et al. CANCER RESEARCH
- Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
- (2013) R. Shao et al. CARCINOGENESIS
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma
- (2013) David A Reardon et al. Expert Review of Vaccines
- Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors
- (2013) Vidyalakshmi Chandramohan et al. Future Oncology
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
- (2013) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients
- (2013) Claudia Januário dos Santos et al. JOURNAL OF MEDICAL VIROLOGY
- PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients
- (2013) Y. Liu et al. JOURNAL OF NEUROSCIENCE
- Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors
- (2013) Lisa L.R. Hartman et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Recurrent H3.3 alterations in childhood tumors
- (2013) Anders M Lindroth et al. NATURE GENETICS
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nature of activatory and tolerogenic dendritic cell-derived signal II
- (2013) Ghaith Bakdash et al. Frontiers in Immunology
- Prognostic Relevance of c-MycandBMI1Expression in Patients With Glioblastoma
- (2012) Tonia Cenci et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments
- (2012) Isabela J. Wastowski et al. AMERICAN JOURNAL OF PATHOLOGY
- α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
- (2012) Yasuto Akiyama et al. BMC CANCER
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors
- (2012) Sofia Eberstål et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Suicide gene therapy in cancer: Where do we stand now?
- (2012) Sónia Duarte et al. CANCER LETTERS
- Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression
- (2012) Sreelatha Gopinath et al. CARCINOGENESIS
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- The cancer antigenome
- (2012) Bianca Heemskerk et al. EMBO JOURNAL
- Expression of β-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations
- (2012) Wenhao Wu et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
- (2012) Pankaj Agarwalla et al. JOURNAL OF IMMUNOTHERAPY
- The art of gene therapy for glioma: a review of the challenging road to the bedside
- (2012) Alex Tobias et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
- (2012) Gabriele Cantini et al. OncoImmunology
- Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
- (2011) D. A. Mitchell et al. BLOOD
- β-catenin and Gli1 are prognostic markers in glioblastoma
- (2011) Marco Rossi et al. CANCER BIOLOGY & THERAPY
- MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
- (2011) Lei Bao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Characterization of Molecular Genetic Alterations in GBMs Highlights a Distinctive Molecular Profile in Young Adults
- (2011) Prerana Jha et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
- (2011) Lin Cheng et al. EMBO JOURNAL
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells
- (2011) Nina Baron et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen
- (2011) Gwendalyn D King et al. MOLECULAR THERAPY
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization and overcomes temozolomide resistance in malignant gliomas
- (2010) I M Germano et al. CANCER GENE THERAPY
- Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma
- (2010) Magdalena Zakrzewska et al. CHILDS NERVOUS SYSTEM
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
- (2010) Ce Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
- (2010) N. Ahmed et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme
- (2010) Mizuhiko Terasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
- (2010) Gaspar J. Kitange et al. JOURNAL OF NEURO-ONCOLOGY
- The detection of CMV pp65 and IE1 in glioblastoma multiforme
- (2010) Kenneth G. Lucas et al. JOURNAL OF NEURO-ONCOLOGY
- Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions
- (2010) Tony Avril et al. JOURNAL OF NEUROIMMUNOLOGY
- Expression of PROX1 Is a Common Feature of High-Grade Malignant Astrocytic Gliomas
- (2010) Tamador Elsir et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes
- (2010) R. Senetta et al. NEURO-ONCOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
- (2010) Leos Kren et al. NEUROPATHOLOGY
- Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
- (2010) F. Orzan et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
- (2010) Laura J. Lewis-Tuffin et al. PLoS One
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- (2009) Amy B Heimberger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status
- (2009) Valeria Barresi et al. HUMAN PATHOLOGY
- Costimulatory and coinhibitory receptors in anti-tumor immunity
- (2009) Gregory Driessens et al. IMMUNOLOGICAL REVIEWS
- Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas
- (2009) Chien-Tsun Kuan et al. INTERNATIONAL JOURNAL OF CANCER
- MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
- (2009) Oscar Persson et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
- (2009) Lara Driggers et al. JOURNAL OF NEURO-ONCOLOGY
- Gli1 is a potential target for alleviating multidrug resistance of gliomas
- (2009) Daming Cui et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers
- (2009) Sine Reker Hadrup et al. NATURE METHODS
- Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
- (2009) Gangadhara Reddy Sareddy et al. NEUROCHEMISTRY INTERNATIONAL
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
- (2009) Qijin Xu et al. STEM CELLS
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth
- (2008) S. Bao et al. CANCER RESEARCH
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
- Interleukin-13 Receptor 2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
- (2008) J. Wykosky et al. CLINICAL CANCER RESEARCH
- Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
- (2008) Rae Myers et al. HUMAN GENE THERAPY
- Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor
- (2008) Minoru Kogiku et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TIMs: central regulators of immune responses: Figure 1.
- (2008) David A. Hafler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy
- (2008) Toshihiko Wakabayashi et al. JOURNAL OF GENE MEDICINE
- Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
- (2008) Jian Gang Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
- (2008) E Antonio Chiocca et al. MOLECULAR THERAPY
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
- Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model
- (2007) Gwendalyn D. King et al. NEURO-ONCOLOGY
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now